Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 5
Submit an article Journal homepage
128
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study

Brian D. Rankina Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaORCID Iconhttps://orcid.org/0000-0001-9283-6312
ORCID Icon,
Jorge-Ryan Georgakopoulosb Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
,
Muskaan Sachdevaw Faculty of Medicine, University of Toronto, Toronto, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0002-2252-5663
ORCID Icon,
Asfandyar Muftib Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
,
Alim R. Devanic Dermatology Research Institute, Calgary, Alberta, Canada;d Skin Health & Wellness Centre, Calgary, Alberta, Canada;e Probity Medical Research, Calgary, Alberta, Canada
,
Melinda J. Gooderhamf Queen's University, Kingston, Ontario, Canada;g SKiN Centre for Dermatology, Peterborough, Ontario, Canada;h Probity Medical Research, Peterborough, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0001-8926-0113
ORCID Icon,
Chih-Ho Hongi Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada;j Dr. Chih-Ho Hong Medical Inc, Surrey, British Columbia,CanadaORCID Iconhttps://orcid.org/0000-0001-9963-8319
ORCID Icon,
Vipul Jaink Division of Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada;l Niagara Region Medical, Niagara Falls, Ontario, Canada;m Allergy Research Canada Inc, Niagara Falls, Ontario, Canada;n Probity Medical Research, Niagara Falls, Ontario, Canada
,
Perla Lansangb Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada;o Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;p Section of Paediatric Dermatology, Department of Paediatric Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
,
Ronald Vendert Department of Dermatology, McMaster University, Hamilton, Ontario, Canada;u Dermatrials Research Inc. & Venderm Innovations in Psoriasis, Hamilton, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0002-2624-2724
ORCID Icon,
Jensen Yeungb Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada;o Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada;p Section of Paediatric Dermatology, Department of Paediatric Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada;q Probity Medical Research Inc, Waterloo, Ontario, CanadaORCID Iconhttps://orcid.org/0000-0002-7318-5515
ORCID Icon &
Vimal H. Prajapatic Dermatology Research Institute, Calgary, Alberta, Canada;d Skin Health & Wellness Centre, Calgary, Alberta, Canada;e Probity Medical Research, Calgary, Alberta, Canada;r Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada;s Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada;v Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8315-2522
ORCID Icon show all
Pages 2692-2694 | Received 04 Jan 2022, Accepted 27 Jan 2022, Published online: 21 Apr 2022

References

  • Georgakopoulos JR, Mufti A, Vender R, et al. Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicentre retrospective cohort study. J Eur Acad Dermatol Venereol. 2021;35(8):e485–e487.
  • Wollenberg A, Flohr C, Simon D, et al. European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis. J Eur Acad Dermatol Venereol. 2020;34(6):e241–e242.
  • Vultaggio A, Agache I, Akdis CA, et al. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: an EAACI statement. Allergy. 2020;75(11):2764–2774.
  • Chiricozzi A, Talamonti M, De Simone C, et al. Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry. Allergy. 2021;76(6):1813–1824.
  • Ferrucci S, Romagnuolo M, Angileri L, et al. Safety of dupilumab in severe atopic dermatitis and infection of covid-19: two case reports. J Eur Acad Dermatol Venereol. 2020;34(7):e303–e304.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.